Anti-Glutamate Receptor 2 as a New Potential Diagnostic Probe for Prostatic Adenocarcinoma

Applied Immunohistochemistry and Molecular Morphology - United States
doi 10.1097/pai.0b013e31824013ba
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Serum Anti-Eif3a Autoantibody as a Potential Diagnostic Marker for Hepatocellular Carcinoma

Scientific Reports
Multidisciplinary
2019English

Soluble Fas Might Serve as a Diagnostic Tool for Gastric Adenocarcinoma

BMC Cancer
Cancer ResearchOncologyGenetics
2010English

Prognostic Significance of High Androgen Receptor Expression in Prostatic Acinar Adenocarcinoma

Asian Pacific Journal of Cancer Prevention
2019English

Foamy Gland Variant of Prostatic Adenocarcinoma (FGVPA), Diagnostic Pitfalls: A Case Report and Literature Review

Pathology
Forensic MedicinePathology
2020English

Anti-Alprenolol Antibodies in the Rabbit. A New Probe for the Study of Beta-Adrenergic Receptor Interaction

Circulation Research
Cardiovascular MedicinePhysiologyCardiology
1980English

Anti-Mda5 Antibody as a Potential Diagnostic and Prognostic Biomarker in Patients With Dermatomyositis

Oncotarget
Oncology
2017English

Benign Mimics of Prostatic Adenocarcinoma

Modern Pathology
Forensic MedicinePathology
2018English

Inverse Relationship Between Leydig Cell Density and Metastatic Potential of Prostatic Adenocarcinoma

Analytical Cellular Pathology
1999English

Prostatic Adenocarcinoma, Diagnosis “Gleason Score”

Journal of Clinical Review & Case Reports
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy